Cardlytics, Inc.
CDLXNASDAQCommunication Services● Active
$5.98
+$5.37(+880.82%)
Market Cap$344712509
P/E Ratio—
52W High$5.984
52W Low$0.55
Cardlytics, Inc. (CDLX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CDLX · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.25
Est. -$0.37 · +32.4%
Revenue
$0.03B
Est. $0.04B · -7.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue🔥 5-Quarter EPS Beat Streak
CDLX reports quarterly as a NASDAQ-listed Advertising Agencies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $7.60B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$7.60B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | -$0.23 | — | — | — | $0.04B | — |
| ▲ Q2 FY2026 | May 7, 2026 | -$0.37 | -$0.25 | +32.4% | $0.03B | $0.04B | -7.7% |
| ▲ Q1 FY2026 | Mar 4, 2026 | -$0.21 | -$0.15 | +27.4% | $0.06B | $0.05B | +3.0% |
| — Q4 FY2025 | Nov 5, 2025 | -$0.07 | -$0.07 | +0.0% | $0.05B | $0.05B | -4.5% |
| ▲ Q3 FY2025 | Aug 6, 2025 | -$0.16 | -$0.13 | +18.8% | $0.06B | $0.06B | -1.2% |
| ▲ Q2 FY2025 | May 7, 2025 | -$0.27 | -$0.21 | +22.2% | $0.06B | $0.06B | +6.7% |
| ▼ Q1 FY2025 | Mar 12, 2025 | -$0.24 | -$0.31 | -29.2% | $0.07B | $0.06B | +20.8% |
| ▲ Q4 FY2024 | Nov 6, 2024 | -$0.33 | -$0.15 | +54.5% | $0.07B | $0.06B | +16.0% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
-$0.23
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
-$0.25
EPS Est.
-$0.37
EPS Surpr.
+32.4%
Revenue
$0.03B
Q1 FY2026
Mar 4, 2026Beat
EPS Actual
-$0.15
EPS Est.
-$0.21
EPS Surpr.
+27.4%
Revenue
$0.06B
Q4 FY2025
Nov 5, 2025
EPS Actual
-$0.07
EPS Est.
-$0.07
EPS Surpr.
+0.0%
Revenue
$0.05B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
-$0.13
EPS Est.
-$0.16
EPS Surpr.
+18.8%
Revenue
$0.06B
Q2 FY2025
May 7, 2025Beat
EPS Actual
-$0.21
EPS Est.
-$0.27
EPS Surpr.
+22.2%
Revenue
$0.06B
Q1 FY2025
Mar 12, 2025Miss
EPS Actual
-$0.31
EPS Est.
-$0.24
EPS Surpr.
-29.2%
Revenue
$0.07B
Q4 FY2024
Nov 6, 2024Beat
EPS Actual
-$0.15
EPS Est.
-$0.33
EPS Surpr.
+54.5%
Revenue
$0.07B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.11 | $-0.11 | $-0.11 | 1 |
| Q3 FY2027 | $-0.16 | $-0.16 | $-0.16 | 1 |
| Q2 FY2027 | $-0.21 | $-0.21 | $-0.21 | 1 |
| Q1 FY2027 | $-0.26 | $-0.26 | $-0.25 | 1 |
| Q4 FY2026 | $-0.19 | $-0.18 | $-0.18 | 1 |
| Q3 FY2026 | $-0.36 | $-0.21 | $-0.10 | 3 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +32.4% | $0.80 | $0.78 | -1.65% |
| ▲ Q1 FY2026 | Mar 4, 2026 | +27.4% | $0.83 | $0.90 | +8.53% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +0.0% | $1.74 | $1.76 | +1.15% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +18.8% | $1.84 | $1.76 | -4.35% |
| ▲ Q2 FY2025 | May 7, 2025 | +22.2% | $2.15 | $2.16 | +0.47% |
| ▼ Q1 FY2025 | Mar 12, 2025 | -29.2% | $2.02 | $1.98 | -1.98% |
| ▲ Q4 FY2024 | Nov 6, 2024 | +54.5% | $4.69 | $5.21 | +11.09% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +28.6% | $7.32 | $6.90 | -5.74% |
Q2 FY2026-1.65%
Report Date
May 7, 2026
EPS Beat/Miss
+32.4%
Price Before
$0.80
Price After
$0.78
Q1 FY2026+8.53%
Report Date
Mar 4, 2026
EPS Beat/Miss
+27.4%
Price Before
$0.83
Price After
$0.90
Q4 FY2025+1.15%
Report Date
Nov 5, 2025
EPS Beat/Miss
+0.0%
Price Before
$1.74
Price After
$1.76
Q3 FY2025-4.35%
Report Date
Aug 6, 2025
EPS Beat/Miss
+18.8%
Price Before
$1.84
Price After
$1.76
Q2 FY2025+0.47%
Report Date
May 7, 2025
EPS Beat/Miss
+22.2%
Price Before
$2.15
Price After
$2.16
Q1 FY2025-1.98%
Report Date
Mar 12, 2025
EPS Beat/Miss
-29.2%
Price Before
$2.02
Price After
$1.98
Q4 FY2024+11.09%
Report Date
Nov 6, 2024
EPS Beat/Miss
+54.5%
Price Before
$4.69
Price After
$5.21
Q3 FY2024-5.74%
Report Date
Aug 7, 2024
EPS Beat/Miss
+28.6%
Price Before
$7.32
Price After
$6.90
Avg Beat Reaction+1.36%
Avg Miss Reaction-1.98%
Beat Rate7 / 8 quarters
Largest Move+11.09% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CDLX ends December
Cardlytics, Inc. (CDLX) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.25 — beating the analyst consensus of $-0.37 by +32.4%. CDLX has beaten EPS estimates for 5 consecutive quarters. The next CDLX earnings date is expected around September 1, 2026.
Each quarter, investors track CDLX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CDLX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CDLX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CDLX earnings · 5 questionsCardlytics, Inc.'s next earnings report is expected around September 1, 2026. CDLX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CDLX historically reports after market close (AMC).
CDLX earnings datewhen is CDLX earningsCDLX next earnings datewhen does CDLX report earningsCDLX earnings calendar
▸ Source: FMP · Cardlytics, Inc. SEC filings · US GAAP · Cardlytics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026